Effectiveness and cost-effectiveness of behavioural support for prolonged abstinence for smokers wishing to reduce but not quit: Randomised controlled trial of physical activity assisted reduction of smoking (TARS).

AIMS For smokers unmotivated to quit, we assessed the effectiveness and cost-effectiveness of behavioural support to reduce smoking and increase physical activity on prolonged abstinence and related outcomes. DESIGN A multi-centred pragmatic two-arm parallel randomised controlled trial. SETTING Primary care and the community across four United Kingdom sites. PARTICIPANTS Nine hundred and fifteen adult smokers (55% female, 85% White), recruited via primary and secondary care and the community, who wished to reduce their smoking but not quit. INTERVENTIONS Participants were randomised to support as usual (SAU) (n = 458) versus multi-component community-based behavioural support (n = 457), involving up to eight weekly person-centred face-to-face or phone sessions with additional 6-week support for those wishing to quit. MEASUREMENTS Ideally, cessation follows smoking reduction so the primary pre-defined outcome was biochemically verified 6-month prolonged abstinence (from 3-9 months, with a secondary endpoint also considering abstinence between 9 and 15 months). Secondary outcomes included biochemically verified 12-month prolonged abstinence and point prevalent biochemically verified and self-reported abstinence, quit attempts, number of cigarettes smoked, pharmacological aids used, SF12, EQ-5D and moderate-to-vigorous physical activity (MVPA) at 3 and 9 months. Intervention costs were assessed for a cost-effectiveness analysis. FINDINGS Assuming missing data at follow-up implied continued smoking, nine (2.0%) intervention participants and four (0.9%) SAU participants achieved the primary outcome (adjusted odds ratio, 2.30; 95% confidence interval [CI] = 0.70-7.56, P = 0.169). At 3 and 9 months, the proportions self-reporting reducing cigarettes smoked from baseline by ≥50%, for intervention versus SAU, were 18.9% versus 10.5% (P = 0.009) and 14.4% versus 10% (P = 0.044), respectively. Mean difference in weekly MVPA at 3 months was 81.6 minutes in favour of the intervention group (95% CI = 28.75, 134.47: P = 0.003), but there was no significant difference at 9 months (23.70, 95% CI = -33.07, 80.47: P = 0.143). Changes in MVPA did not mediate changes in smoking outcomes. The intervention cost was £239.18 per person, with no evidence of cost-effectiveness. CONCLUSIONS For United Kingdom smokers wanting to reduce but not quit smoking, behavioural support to reduce smoking and increase physical activity improved some short-term smoking cessation and reduction outcomes and moderate-to-vigorous physical activity, but had no long-term effects on smoking cessation or physical activity.

[1]  Adrian H. Taylor,et al.  Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT. , 2023, Health technology assessment.

[2]  Megan E. Piper,et al.  Evaluating Four Motivation-Phase Intervention Components for Use with Primary Care Patients Unwilling to Quit Smoking: A Randomized Factorial Experiment. , 2021, Addiction.

[3]  M. Cabana,et al.  Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[4]  S. Jordt,et al.  What are the respiratory effects of e-cigarettes? , 2019, BMJ.

[5]  Megan E. Piper,et al.  Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment. , 2019, Drug and alcohol dependence.

[6]  J. Twisk,et al.  Comparison of logistic-regression based methods for simple mediation analysis with a dichotomous outcome variable , 2019, BMC Medical Research Methodology.

[7]  Adrian H. Taylor,et al.  Intervention Delivery Fidelity Assessment of a Counseling-Based Intervention for Promoting Smoking Reduction and Increasing Physical Activity , 2018, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[8]  James R. Fingar,et al.  Motivational, reduction and usual care interventions for smokers who are not ready to quit: a randomized controlled trial , 2017, Addiction.

[9]  C. Patten,et al.  A Randomized Trial of Motivational Interviewing: Cessation Induction Among Smokers With Low Desire to Quit. , 2016, American journal of preventive medicine.

[10]  S. Michie,et al.  An Exploratory Analysis of the Smoking and Physical Activity Outcomes From a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups. , 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[11]  Megan E. Piper,et al.  Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment. , 2016, Addiction.

[12]  Megan E. Piper,et al.  Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment. , 2016, Addiction.

[13]  T. Coleman,et al.  Do cravings predict smoking cessation in smokers calling a national quit line: secondary analyses from a randomised trial for the utility of ‘urges to smoke’ measures , 2015, Substance Abuse Treatment, Prevention, and Policy.

[14]  M. Sayette,et al.  Neuroimaging craving: urge intensity matters. , 2015, Addiction.

[15]  Adrian H. Taylor,et al.  The acute effects of physical activity on cigarette cravings: Exploration of potential moderators, mediators and physical activity attributes using individual participant data (IPD) meta-analyses , 2014, Psychopharmacology.

[16]  Robert West,et al.  A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers. , 2014, Health technology assessment.

[17]  T. Kohlmann,et al.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[18]  Megan E. Piper,et al.  The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions , 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[19]  M. Connock,et al.  Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[20]  Robert West,et al.  Outcome criteria in smoking cessation trials: proposal for a common standard. , 2005, Addiction.

[21]  J. Hughes,et al.  Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. , 2004, Journal of consulting and clinical psychology.

[22]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[23]  R C Frecker,et al.  Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. , 1989, British journal of addiction.

[24]  K. Vranizan,et al.  Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. , 1985, American journal of epidemiology.